ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies. [AUT. KORESP.] SARAH ELITZUR, [AUT.] RUTH SHILOH, JAN L.C. LOEFFEN, AGATA PASTORCZAK, MASATOSHI TAKAGI, SIMON BOMKEN, ANDRE BARUCHEL, THOMAS LEHRNBECHER, SARAH K. TASIAN, OUSSAMA ABLA, NIRA ARAD-COHEN, ITZIAR ASTIGARRAGA, MIRIAM BEN-HAROSH, NICOLE BODMER, TRIANTAFYLLIA BROZOU, FRANCESCO CEPPI, LILIIA CHUGAEVA, LUCIANO DALLA POZZA, STEPHANE DUCASSOU, GABRIELE ESCHERICH, ROULA FARAH, AMBER GIBSON, HENRIK HASLE, JULIETA HOVEYAN, ELAD JACOBY, JANEZ JAZBEC, STEFANIE JUNK, ALEXANDRA KOLENOVA, JELENA LAZIC, LUCA LO NIGRO, NIZAR MAHLAOUI, LANE MILLER, VASSILIOS PAPADAKIS, LUCIE PECHEUX, MARTA PILLON, IFAT SAROUK, JAN STARY, EFTICHIA STIAKAKI, MARION STRULLU, THAI HOA TRAN, MAREK USSOWICZ, JAIME VERDU-AMOROS, ANNA WAKULIŃSKA, JOANNA ZAWITKOWSKA, DOMINIQUE STOPPA-LYONNET, A. MALCOLM TAYLOR, YOSEF SHILOH, SHAI IZRAELI, VERONIQUE MINARD-COLIN, KJELD SCHMIEGELOW, RONIT NIREL, ANDISHE ATTARBASCHI, ARNDT BORKHARDT. Blood 2024 vol. 144 nr 11 s. 1193-1205, bibliogr. poz. 53. DOI: 10.1182/blood.2024024283